Is AI dictating affected person care? What occurs when your financial institution falls aside? And will Illumina bear some shareholder activism?
We duvet all that and extra this week at the 250th episode of âThe Readout LOUD,â STATâs biotech podcast. STAT reporter Bob Herman joins us to give an explanation for how remedy algorithms powered via synthetic intelligence are getting used extra continuously via Medicare Benefit plans to disclaim claims, even if endured remedy is medically justified. Weâll additionally talk about the most recent information within the lifestyles sciences, together with the continuing fallout of the run on Silicon Valley Financial institution, the go back of Carl Icahn, and a long-awaited pharmaceutical megadeal.
For extra on what we duvet, right hereâs the tale on AI and Medicare Benefit; right hereâs the most recent on SVB; right hereâs the inside track on Illumina; right hereâs extra on Pfizer purchasing Seagen;Â right hereâs the place you’ll in finding episodes of Colour Code; and right hereâs the place you’ll subscribe to the First Opinion Podcast.
And if in case you have any comments for us â subjects to hide, visitors to ask, vocal tics to stop â you’ll e-mail [emailÂ protected].